Literature DB >> 33539351

Maximal surgical resection and adjuvant surgical technique to prolong the survival of adult patients with thalamic glioblastoma.

Jaejoon Lim1, YoungJoon Park1,2,3, Ju Won Ahn1,2, So Jung Hwang1, Hyouksang Kwon1, Kyoung Su Sung4, Kyunggi Cho1.   

Abstract

The importance of maximal resection in the treatment of glioblastoma (GBM) has been reported in many studies, but maximal resection of thalamic GBM is rarely attempted due to high rate of morbidity and mortality. The purpose of this study was to investigate the role of surgical resection in adult thalamic glioblastoma (GBM) treatment and to identify the surgical technique of maximal safety resection. In case of suspected thalamic GBM, surgical resection is the treatment of choice in our hospital. Biopsy was considered when there was ventricle wall enhancement or multiple enhancement lesion in a distant location. Navigation magnetic resonance imaging, diffuse tensor tractography imaging, tailed bullets, and intraoperative computed tomography and neurophysiologic monitoring (transcranial motor evoked potential and direct subcortical stimulation) were used in all surgical resection cases. The surgical approach was selected on the basis of the location of the tumor epicenter and the adjacent corticospinal tract. Among the 42 patients, 19 and 23 patients underwent surgical resection and biopsy, respectively, according to treatment strategy criteria. As a result, the surgical resection group exhibited a good response with overall survival (OS) (median: 676 days, p < 0.001) and progression-free survival (PFS) (median: 328 days, p < 0.001) compared with each biopsy groups (doctor selecting biopsy group, median OS: 240 days and median PFS: 134 days; patient selecting biopsy group, median OS: 212 days and median PFS: 118 days). The surgical resection groups displayed a better prognosis compared to that of the biopsy groups for both the O6-methylguanine-DNA methyltransferase unmethylated (log-rank p = 0.0035) or methylated groups (log-rank p = 0.021). Surgical resection was significantly associated with better prognosis (hazard ratio: 0.214, p = 0.006). In case of thalamic GBM without ventricle wall-enhancing lesion or multiple lesions, maximal surgical resection above 80% showed good clinical outcomes with prolonged the overall survival compared to biopsy. It is helpful to use adjuvant surgical techniques of checking intraoperative changes and select the appropriate surgical approach for reducing the surgical morbidity.

Entities:  

Year:  2021        PMID: 33539351      PMCID: PMC7861362          DOI: 10.1371/journal.pone.0244325

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  43 in total

1.  Thalamic high-grade gliomas in children: a distinct clinical subset?

Authors:  Christof M Kramm; Sandra Butenhoff; Ulrike Rausche; Monika Warmuth-Metz; Rolf-Dieter Kortmann; Torsten Pietsch; Astrid Gnekow; Norbert Jorch; Gisela Janssen; Frank Berthold; Johannes E Wolff
Journal:  Neuro Oncol       Date:  2011-06       Impact factor: 12.300

2.  Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period.

Authors:  Shawn L Hervey-Jumper; Jing Li; Darryl Lau; Annette M Molinaro; David W Perry; Lingzhong Meng; Mitchel S Berger
Journal:  J Neurosurg       Date:  2015-04-24       Impact factor: 5.115

3.  Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.

Authors:  Walter Stummer; Martin J van den Bent; Manfred Westphal
Journal:  Acta Neurochir (Wien)       Date:  2011-04-09       Impact factor: 2.216

4.  Contribution of combined intraoperative electrophysiological investigation with 3-T intraoperative MRI for awake cerebral glioma surgery: comprehensive review of the clinical implications and radiological outcomes.

Authors:  Diana Ghinda; Nan Zhang; Junfeng Lu; Cheng-Jun Yao; Shiwen Yuan; Jin-Song Wu
Journal:  Neurosurg Focus       Date:  2016-03       Impact factor: 4.047

5.  Distant recurrences limit the survival of patients with thalamic high-grade gliomas after successful resection.

Authors:  Ryuta Saito; Toshihiro Kumabe; Masayuki Kanamori; Yukihiko Sonoda; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2016-12-17       Impact factor: 3.042

6.  High-grade thalamic gliomas: Microsurgical treatment and prognosis analysis.

Authors:  Biwu Wu; Chao Tang; Yang Wang; Zhiqi Li; Shukun Hu; Wei Hua; Wengang Li; Shan Huang; Junfeng Ma; Yi Zhang
Journal:  J Clin Neurosci       Date:  2017-12-14       Impact factor: 1.961

7.  Supratotal resection in glioma: a systematic review.

Authors:  Charles N de Leeuw; Michael A Vogelbaum
Journal:  Neuro Oncol       Date:  2019-02-14       Impact factor: 12.300

8.  Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas.

Authors:  Kazuya Motomura; Atsushi Natsume; Kentaro Iijima; Shunichiro Kuramitsu; Masazumi Fujii; Takashi Yamamoto; Satoshi Maesawa; Junko Sugiura; Toshihiko Wakabayashi
Journal:  J Neurosurg       Date:  2017-01-06       Impact factor: 5.115

9.  H3F3A K27M mutations in thalamic gliomas from young adult patients.

Authors:  Koki Aihara; Akitake Mukasa; Kengo Gotoh; Kuniaki Saito; Genta Nagae; Shingo Tsuji; Kenji Tatsuno; Shogo Yamamoto; Shunsaku Takayanagi; Yoshitaka Narita; Soichiro Shibui; Hiroyuki Aburatani; Nobuhito Saito
Journal:  Neuro Oncol       Date:  2013-11-26       Impact factor: 12.300

10.  Surgical management of thalamic gliomas: case selection, technical considerations, and review of literature.

Authors:  Narayanam Anantha Sai Kiran; Sumit Thakar; Ravi Dadlani; Dilip Mohan; Sunil Valentine Furtado; Nandita Ghosal; Saritha Aryan; Alangar S Hegde
Journal:  Neurosurg Rev       Date:  2013-01-25       Impact factor: 3.042

View more
  2 in total

1.  Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.

Authors:  Yulun Huang; Lin Qi; Mari Kogiso; Yuchen Du; Frank K Braun; Huiyuan Zhang; L Frank Huang; Sophie Xiao; Wan-Yee Teo; Holly Lindsay; Sibo Zhao; Patricia Baxter; Jack M F Su; Adekunle Adesina; Jianhua Yang; Sebastian Brabetz; Marcel Kool; Stefan M Pfister; Murali Chintagumpala; Laszlo Perlaky; Zhong Wang; Youxin Zhou; Tsz-Kwong Man; Xiao-Nan Li
Journal:  Adv Sci (Weinh)       Date:  2021-11-01       Impact factor: 16.806

Review 2.  Intraoperative MR Imaging during Glioma Resection.

Authors:  Mitsunori Matsumae; Jun Nishiyama; Kagayaki Kuroda
Journal:  Magn Reson Med Sci       Date:  2021-12-09       Impact factor: 2.760

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.